Christopher Chang, MD, Gastroenterology, Albuquerque, NM, University of New Mexico Hospitals

ChristopherHan ShengChangMD

Gastroenterology Albuquerque, NM

Clinical Instructor, Medicine; Digestive Diseases/Gastroenterology, UCLA School of Medicine

Are you Dr. Chang?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Connect with colleagues in the same hospital or clinic
    You already have 38 invites waiting!
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

  • Office

    1501 San Pedro Dr Se
    Medicine Service, Box 111
    Albuquerque, NM 87108
    Phone(505) 265-1711
    Fax(505) 256-2803
  • Is this information wrong?

Summary

  • Dr. Christopher Chang, MD is a gastroenterologist in Albuquerque, New Mexico. He is currently licensed to practice medicine in New Mexico, New Jersey, and Delaware. He is affiliated with University of New Mexico Hospitals and is a Clinical Instructor at UCLA School of Medicine.

Education & Training

  • UCLA Medical Center
    UCLA Medical CenterFellowship, Gastroenterology, 1997 - 2001
  • UCLA Medical Center
    UCLA Medical CenterResidency, Internal Medicine, 1995 - 1997
  • University of California San Francisco School of Medicine
    University of California San Francisco School of MedicineClass of 1995

Certifications & Licensure

  • NM State Medical License
    NM State Medical License 2015 - 2022
  • NJ State Medical License
    NJ State Medical License 2011 - 2015
  • DE State Medical License
    DE State Medical License 2010 - 2015
  • PA State Medical License
    PA State Medical License 2010 - 2014
  • CA State Medical License
    CA State Medical License 1997 - 2020
  • OR State Medical License
    OR State Medical License 1997 - 2013
  • American Board of Internal Medicine Gastroenterology

Publications & Presentations

PubMed

Press Mentions

  • Development and Validation of a Biomarker for Diarrhea-Predominant Irritable Bowel Syndrome in Human Subjects
    Development and Validation of a Biomarker for Diarrhea-Predominant Irritable Bowel Syndrome in Human SubjectsMay 13th, 2020

Grant Support

  • DFT Investigations Of Mn(Ii/Iii) Oxalate Oxidase ModelsNational Institute Of Diabetes And Digestive And Kidney Diseases2002–2003

Hospital Affiliations